PTC Therapeutics Provides Regulatory Update on Translarna (August 2016)
by: Parent Project Muscular Dystrophy
PTC Therapeutics Provides Regulatory Update on Translarna (August 2016)
On August 1, 2016, PPMD hosted a webinar with PTC Therapeutics to discuss the latest news regarding Translarna. Craig McDonald presented the benefits of Translarna from emerging data and senior leadership from PTC were on hand to answer questions regarding the path forward for the therapy with the FDA.
by: Parent Project Muscular Dystrophy
